Pyxis Oncology Stock In The News

PYXS Stock  USD 2.01  0.18  9.84%   
Our overall analysis of Pyxis Oncology's news coverage and content from conventional and social sources shows investors' bearish mood towards Pyxis Oncology. The specific impact of Pyxis Oncology news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Pyxis Oncology's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Pyxis Oncology headlines in addition to utilizing other, more conventional financial analysis modules. Check out Pyxis Oncology Backtesting and Pyxis Oncology Hype Analysis.
For more information on how to buy Pyxis Stock please use our How to Invest in Pyxis Oncology guide.

Pyxis Oncology Today Top News and Investor Outlook

Yahoo News
From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires
https://finance.yahoo.com/news/six-figures-seven-3-biotech-185839292.html
 Bullish
Macroaxis News: globenewswire.com
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
https://www.globenewswire.com/news-release/2023/11/28/2786802/0/en/Pyxis-Oncology-Announces-Appointment-of-Ken-Kobayashi-M-D-F-A-C-P-as-Chief-Medical-Officer.html
 Neutral
Macroaxis News: globenewswire.com
SHAREHOLDER ALERT: Levi & Korsinsky, LLP...
https://www.globenewswire.com/news-release/2023/11/21/2784482/3080/en/SHAREHOLDER-ALERT-Levi-Korsinsky-LLP-Notifies-Shareholders-of-an-Investigation-Concerning-Possible-Breaches-of-Fiduciary-Duty-by-Certain-Officers-and-Directors-of-NAPCO-Security-Te.html
 Neutral
Macroaxis News: globenewswire.com
Pyxis Oncology Announces Initiatives to ...
https://www.globenewswire.com/news-release/2023/11/07/2775688/0/en/Pyxis-Oncology-Announces-Initiatives-to-Prioritize-Lead-ADC-Program-Reports-Financial-Results-for-Third-Quarter-2023-and-Provides-Corporate-Update.html
 Neutral
Macroaxis News: globenewswire.com
SHAREHOLDER ALERT: Levi & Korsinsky, LLP...
https://www.globenewswire.com/news-release/2023/10/26/2767936/3080/en/SHAREHOLDER-ALERT-Levi-Korsinsky-LLP-Notifies-Shareholders-of-an-Investigation-Concerning-Possible-Breaches-of-Fiduciary-Duty-by-Certain-Officers-and-Directors-of-Pyxis-Oncology-In.html
 Neutral
Macroaxis News: globenewswire.com
Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023
https://www.globenewswire.com/news-release/2023/09/27/2750495/0/en/Pyxis-Oncology-Announces-Four-Abstracts-Accepted-for-Poster-Presentation-at-Society-for-Immunotherapy-of-Cancer-SITC-2023.html
 Neutral
Macroaxis News: globenewswire.com
Pyxis Oncology to Participate in Two Upcoming Investment Conferences
https://www.globenewswire.com/news-release/2023/08/31/2735677/0/en/Pyxis-Oncology-to-Participate-in-Two-Upcoming-Investment-Conferences.html
 Neutral
Macroaxis News: globenewswire.com
Pyxis Oncology Successfully Completes Acquisition of Apexigen
https://www.globenewswire.com/news-release/2023/08/23/2730427/0/en/Pyxis-Oncology-Successfully-Completes-Acquisition-of-Apexigen.html
 Bullish
Macroaxis News: globenewswire.com
Pyxis Oncology Reports Financial Results for Second-Quarter 2023 and Provides Corporate Update
https://www.globenewswire.com/news-release/2023/08/11/2723437/0/en/Pyxis-Oncology-Reports-Financial-Results-for-Second-Quarter-2023-and-Provides-Corporate-Update.html
 Neutral
Macroaxis News: globenewswire.com
Pyxis Oncology to Present at BTIG Virtual Biotechnology Conference
https://www.globenewswire.com/news-release/2023/08/01/2716361/0/en/Pyxis-Oncology-to-Present-at-BTIG-Virtual-Biotechnology-Conference.html
 Neutral

Pyxis Oncology Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Pyxis and other traded companies coverage with news coverage. We help investors stay connected with Pyxis headlines for the 30th of November to make an informed investment decision based on correlating the impacts of news items on Pyxis Stock performance. Please note that trading solely based on the Pyxis Oncology hype is not for everyone as timely availability and quick action are needed to avoid losses.
Pyxis Oncology's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Pyxis Oncology investors visualize upcoming and past events in order to time the market based on Pyxis Oncology noise-free hype analysis.
Pyxis Oncology stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Pyxis earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Pyxis Oncology that are available to investors today. That information is available publicly through Pyxis media outlets and privately through word of mouth or via Pyxis internal channels. However, regardless of the origin, that massive amount of Pyxis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pyxis Oncology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pyxis Oncology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pyxis Oncology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pyxis Oncology alpha.

Pyxis Largest EPS Surprises

Earnings surprises can significantly impact Pyxis Oncology's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-12
2024-09-30-0.31-0.35-0.0412 
2024-03-21
2023-12-31-0.47-0.330.1429 
2024-05-14
2024-03-31-0.24-0.060.1875 
2023-08-11
2023-06-30-0.65-0.410.2436 
2023-05-11
2023-03-31-0.9-0.550.3538 
2022-05-13
2022-03-31-0.61-0.97-0.3659 
View All Earnings Estimates

Pyxis Oncology Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Pyxis Oncology Stock. Current markets are slightly bearish. About 51% of major world exchanges and indexes are down. See today's market update for more information.
Macroaxis News
26th of November 2024
Acquisition by Connealy Pamela Ann of 5450 shares of Pyxis Oncology at 2.0 subject to Rule...
at MacroaxisInsider 
Investing News at Macroaxis
21st of November 2024
PYXS shares target upgraded, outperform on positive trial data
at investing.com 
news
18th of November 2024
Pyxis Oncology, Inc. Short Interest Update
at thelincolnianonline.com 
Macroaxis News: globenewswire.com
11th of November 2024
Pyxis Oncology to Host In-Person and Virtual Investor Event on Wednesday, November 20, 202...
at globenewswire.com 
Google News at Macroaxis
13th of September 2024
Moment Of Truth Approaches For Pyxis Oncology - Seeking Alpha
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pyxis Oncology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pyxis Oncology's short interest history, or implied volatility extrapolated from Pyxis Oncology options trading.

Additional Tools for Pyxis Stock Analysis

When running Pyxis Oncology's price analysis, check to measure Pyxis Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pyxis Oncology is operating at the current time. Most of Pyxis Oncology's value examination focuses on studying past and present price action to predict the probability of Pyxis Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pyxis Oncology's price. Additionally, you may evaluate how the addition of Pyxis Oncology to your portfolios can decrease your overall portfolio volatility.